Show notes are at https://stevelitchfield.com/sshow/chat.html
…
continue reading
Innhold levert av NFX. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av NFX eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!
Gå frakoblet med Player FM -appen!
The Past, Present, and Future of Longevity w/ Joe Betts-LaCroix Alex Colville
MP3•Episoder hjem
Manage episode 411753731 series 2879578
Innhold levert av NFX. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av NFX eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
In this episode, Omri Amirav-Drory (NFX), Joe Betts-LaCroix (Retro Bio), and Alex Colville (Age1) discuss the history, recent progress, and hurdles in the longevity industry, including the evaluation of potential founders and business risks. The discussion further encompasses the global fundraising potential and societal impact of the longevity sector, viewing aging as a disease, and the future of longevity drugs. Learn more at - https://nfx.com/bio (0:00) Introduction and Overview of Longevity Science (4:21) Transition from Scientist to Investor: Alex Colville's Journey (8:16) Current Advancements in Biology and Aging Field (12:15) Cutting Edge Topics in Longevity Space (20:02) Evaluating Potential Founders and Startups in the Longevity Space (22:08) Challenges in Longevity Field: FDA Approval and Mission Focus (23:46) Risks and Investment in the Biotech Industry (27:24) Misconceptions and Business Case for Longevity (32:34) Societal Effects and Impact of Longevity Drugs (36:08) Advice and Future Challenges for Founders in the Longevity Field (38:04) Closing Remarks and Thanks
…
continue reading
169 episoder
MP3•Episoder hjem
Manage episode 411753731 series 2879578
Innhold levert av NFX. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av NFX eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
In this episode, Omri Amirav-Drory (NFX), Joe Betts-LaCroix (Retro Bio), and Alex Colville (Age1) discuss the history, recent progress, and hurdles in the longevity industry, including the evaluation of potential founders and business risks. The discussion further encompasses the global fundraising potential and societal impact of the longevity sector, viewing aging as a disease, and the future of longevity drugs. Learn more at - https://nfx.com/bio (0:00) Introduction and Overview of Longevity Science (4:21) Transition from Scientist to Investor: Alex Colville's Journey (8:16) Current Advancements in Biology and Aging Field (12:15) Cutting Edge Topics in Longevity Space (20:02) Evaluating Potential Founders and Startups in the Longevity Space (22:08) Challenges in Longevity Field: FDA Approval and Mission Focus (23:46) Risks and Investment in the Biotech Industry (27:24) Misconceptions and Business Case for Longevity (32:34) Societal Effects and Impact of Longevity Drugs (36:08) Advice and Future Challenges for Founders in the Longevity Field (38:04) Closing Remarks and Thanks
…
continue reading
169 episoder
Alle episoder
×Velkommen til Player FM!
Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.